Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Version of Syngo.via Supports Treatment Decision in Oncology

By MedImaging International staff writers
Posted on 01 Jul 2015
Siemens Healthcare has released a new version of oncology diagnostics software that helps physicians plan the best course of treatment for cancer patients.

Cancer treatment requires comprehensive diagnostics, speed, and optimal information exchange with other clinical disciplines. More...
Treatment planning requires the preparation of imaging procedures for the precise assessment of the position, morphology and metabolism of a tumor, and for radiotherapy planning.

The new version of Siemens Healthcare’s (Erlangen, Germany) syngo.via RT Image Suite helps radiotherapy oncologists use imaging information from modalities such as Computed Tomography (CT), Magnetic Resonance Tomography (MRT) or Positron Emission Tomography-CT (PET-CT), to create accurate tumor contours for treatment, with minimal damage to surrounding healthy tissue.

The syngo.via software provides early quantitative feedback about the effectiveness of the treatment, an offline mode for the interdisciplinary information exchange, and support reading and reporting the results of MRI scans.

The syngo.MR OncoCare application enables an early, quantitative evaluation of the treatment, enabling the treating physician to select an alternative treatment method if necessary, saving time and costs. The syngo.MI offline Oncoboard application enables interdisciplinary cancer tumor boards to share syngo.via findings from the various imaging procedures offline on a standard PC. The syngo.via software can be used standalone or together with other syngo.via-based software.

Related Links:

Siemens Healthcare



Adjustable Mobile Barrier
M-458
High-Precision QA Tool
DEXA Phantom
Medical Radiographic X-Ray Machine
TR30N HF
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.